Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 226

1.

Comparison of the safety and efficacy of conventional monopolar and 2-micron laser transurethral resection in the management of multiple nonmuscle-invasive bladder cancer.

Liu H, Wu J, Xue S, Zhang Q, Ruan Y, Sun X, Xia S.

J Int Med Res. 2013 Aug;41(4):984-92. doi: 10.1177/0300060513477001. Epub 2013 Jun 12.

PMID:
23760914
2.

Comparing the safety and efficiency of conventional monopolar, plasmakinetic, and holmium laser transurethral resection of primary non-muscle invasive bladder cancer.

Xishuang S, Deyong Y, Xiangyu C, Tao J, Quanlin L, Hongwei G, Jibin Y, Dongjun W, Zhongzhou H, Jianbo W, Lina W, Lin Y.

J Endourol. 2010 Jan;24(1):69-73. doi: 10.1089/end.2009.0171.

PMID:
19954353
3.

Electromotive instillation of mitomycin immediately before transurethral resection for patients with primary urothelial non-muscle invasive bladder cancer: a randomised controlled trial.

Di Stasi SM, Valenti M, Verri C, Liberati E, Giurioli A, Leprini G, Masedu F, Ricci AR, Micali F, Vespasiani G.

Lancet Oncol. 2011 Sep;12(9):871-9. doi: 10.1016/S1470-2045(11)70190-5. Epub 2011 Aug 8.

PMID:
21831711
4.

En bloc transurethral resection with 2-micron continuous-wave laser for primary non-muscle-invasive bladder cancer: a randomized controlled trial.

Chen X, Liao J, Chen L, Qiu S, Mo C, Mao X, Yang Y, Zhou S, Chen J.

World J Urol. 2015 Jul;33(7):989-95. doi: 10.1007/s00345-014-1342-1. Epub 2014 Jun 21. Erratum in: World J Urol. 2015 Jul;33(7):997.

PMID:
24950758
5.

EFFICACY OF DIFFERENT RESECTIONS ON NON-MUSCLE-INVASIVE BLADDER CANCER AND ANALYSIS OF THE OPTIMAL SURGICAL METHOD.

Chen GF, Shi TP, Wang BJ, Wang XY, Zang Q.

J Biol Regul Homeost Agents. 2015 Apr-Jun;29(2):465-70.

PMID:
26122238
6.

Clinical observation on 2 micron laser for non-muscle-invasive bladder tumor treatment: single-center experience.

Zhong C, Guo S, Tang Y, Xia S.

World J Urol. 2010 Apr;28(2):157-61. doi: 10.1007/s00345-010-0532-8. Epub 2010 Mar 20.

PMID:
20306053
7.

Comparing the treatment outcomes of potassium-titanyl-phosphate laser vaporization and transurethral electroresection for primary nonmuscle-invasive bladder cancer: A prospective, randomized study.

Xu Y, Guan W, Chen W, Xie C, Ouyang Y, Wu Y, Liu C.

Lasers Surg Med. 2015 Apr;47(4):306-11. doi: 10.1002/lsm.22342. Epub 2015 Apr 9.

PMID:
25864416
8.

Safety and efficacy of holmium laser resection for primary nonmuscle-invasive bladder cancer versus transurethral electroresection: single-center experience.

Zhu Y, Jiang X, Zhang J, Chen W, Shi B, Xu Z.

Urology. 2008 Sep;72(3):608-12. doi: 10.1016/j.urology.2008.05.028. Epub 2008 Jul 23.

PMID:
18649930
10.

Plasmakinetic bipolar versus monopolar transurethral resection of non-muscle invasive bladder cancer: a single center randomized controlled trial.

Del Rosso A, Pace G, Masciovecchio S, Saldutto P, Galatioto GP, Vicentini C.

Int J Urol. 2013 Apr;20(4):399-403. doi: 10.1111/j.1442-2042.2012.03174.x. Epub 2012 Sep 25.

11.

Measuring the dimension of invasive component in pT1 urothelial carcinoma in transurethral resection specimens can predict time to recurrence.

Hu Z, Mudaliar K, Quek ML, Paner GP, Barkan GA.

Ann Diagn Pathol. 2014 Apr;18(2):49-52. doi: 10.1016/j.anndiagpath.2013.11.002. Epub 2013 Nov 20.

PMID:
24370460
12.

The value of extended transurethral resection of bladder tumour (TURBT) in the treatment of bladder cancer.

Richterstetter M, Wullich B, Amann K, Haeberle L, Engehausen DG, Goebell PJ, Krause FS.

BJU Int. 2012 Jul;110(2 Pt 2):E76-9. doi: 10.1111/j.1464-410X.2011.10904.x. Epub 2012 Feb 7.

14.

Does the management of bladder perforation during transurethral resection of superficial bladder tumors predispose to extravesical tumor recurrence?

Skolarikos A, Chrisofos M, Ferakis N, Papatsoris A, Dellis A, Deliveliotis C.

J Urol. 2005 Jun;173(6):1908-11.

PMID:
15879773
15.

Good quality white-light transurethral resection of bladder tumours (GQ-WLTURBT) with experienced surgeons performing complete resections and obtaining detrusor muscle reduces early recurrence in new non-muscle-invasive bladder cancer: validation across time and place and recommendation for benchmarking.

Mariappan P, Finney SM, Head E, Somani BK, Zachou A, Smith G, Mishriki SF, N'Dow J, Grigor KM; Edinburgh Urological Cancer Group.

BJU Int. 2012 Jun;109(11):1666-73. doi: 10.1111/j.1464-410X.2011.10571.x. Epub 2011 Nov 1.

16.

Comparing the Efficiency and Safety of Bipolar and Monopolar Transurethral Resection for Non-Muscle Invasive Bladder Tumors: A Systematic Review and Meta-Analysis.

Cui Y, Chen H, Liu L, Chen J, Qi L, Zu X.

J Laparoendosc Adv Surg Tech A. 2016 Mar;26(3):196-202. doi: 10.1089/lap.2015.0507. Epub 2016 Jan 22. Review.

PMID:
26799841
17.

Real-life Experience: Early Recurrence With Hexvix Photodynamic Diagnosis-assisted Transurethral Resection of Bladder Tumour vs Good-quality White Light TURBT in New Non-muscle-invasive Bladder Cancer.

Mariappan P, Rai B, El-Mokadem I, Anderson CH, Lee H, Stewart S, Donat R.

Urology. 2015 Aug;86(2):327-31. doi: 10.1016/j.urology.2015.04.015. Epub 2015 Jul 2.

PMID:
26142924
18.

Holmium laser transurethral resection of bladder tumor: Our experience.

D'souza N, Verma A.

Urol Ann. 2016 Oct-Dec;8(4):439-443. doi: 10.4103/0974-7796.190815.

19.

Tumor recurrence in prostatic urethra following simultaneous resection of bladder tumor and prostate: a comparative retrospective study.

Jaidane M, Bouicha T, Slama A, Hmida W, Hidoussi A, Ben Sorba N, Mosbah F.

Urology. 2010 Jun;75(6):1392-5. doi: 10.1016/j.urology.2009.06.066. Epub 2009 Sep 25.

PMID:
19781747
20.

Comparing the short-term outcomes and complications of monopolar and bipolar transurethral resection of non-muscle invasive bladder cancers: a prospective, randomized, controlled study.

Bolat D, Gunlusoy B, Degirmenci T, Ceylan Y, Polat S, Aydin E, Aydogdu O, Kozacioglu Z.

Arch Esp Urol. 2016 Jun;69(5):225-33.

PMID:
27291558

Supplemental Content

Support Center